OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
Amin Ardestani, Matthew S. Tremblay, Weijun Shen, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Amin Ardestani, Matthew S. Tremblay, Weijun Shen, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Mechanism and therapeutic potential of hippo signaling pathway in type 2 diabetes and its complications
Ziqi Zhao, W.-G. Wu, Qianyi Zhang, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117817-117817
Closed Access
Ziqi Zhao, W.-G. Wu, Qianyi Zhang, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117817-117817
Closed Access
Pharmacological regulators of Hippo pathway: Advances and challenges of drug development
Zhaobai Lao, Xin Chen, Bin Pan, et al.
The FASEB Journal (2025) Vol. 39, Iss. 6
Closed Access
Zhaobai Lao, Xin Chen, Bin Pan, et al.
The FASEB Journal (2025) Vol. 39, Iss. 6
Closed Access
MST1: A future novel target for cardiac diseases
Yingchun Shao, Yanhong Wang, Li Sun, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124296-124296
Closed Access | Times Cited: 10
Yingchun Shao, Yanhong Wang, Li Sun, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124296-124296
Closed Access | Times Cited: 10
The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy
Yunfei Yin, Mingyue Tan, Lianhua Han, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1956-1975
Open Access | Times Cited: 9
Yunfei Yin, Mingyue Tan, Lianhua Han, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1956-1975
Open Access | Times Cited: 9
Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects
Agnieszka Kilanowska, Agnieszka Ziółkowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 636-636
Open Access | Times Cited: 15
Agnieszka Kilanowska, Agnieszka Ziółkowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 636-636
Open Access | Times Cited: 15
The essential role of TAZ in normal tissue homeostasis
Mi Gyeong Jeong, Hyo Kyeong Kim, Eun Sook Hwang
Archives of Pharmacal Research (2021) Vol. 44, Iss. 3, pp. 253-262
Open Access | Times Cited: 17
Mi Gyeong Jeong, Hyo Kyeong Kim, Eun Sook Hwang
Archives of Pharmacal Research (2021) Vol. 44, Iss. 3, pp. 253-262
Open Access | Times Cited: 17
Safety and Efficacy Profile of Neratinib: A Systematic Review and Meta-Analysis of 23 Prospective Clinical Trials
Zhi‐Hang Tao, Stanley Xiangyu Li, Kai Shen, et al.
Clinical Drug Investigation (2018) Vol. 39, Iss. 1, pp. 27-43
Closed Access | Times Cited: 18
Zhi‐Hang Tao, Stanley Xiangyu Li, Kai Shen, et al.
Clinical Drug Investigation (2018) Vol. 39, Iss. 1, pp. 27-43
Closed Access | Times Cited: 18
MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target
Samuel O. Abegunde, Stacy Grieve, Helmi Alfarra, et al.
Experimental Hematology (2023) Vol. 123, pp. 34-45
Closed Access | Times Cited: 5
Samuel O. Abegunde, Stacy Grieve, Helmi Alfarra, et al.
Experimental Hematology (2023) Vol. 123, pp. 34-45
Closed Access | Times Cited: 5
Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
Vasileios Angelis, Stephen R.D. Johnston, Amin Ardestani, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Vasileios Angelis, Stephen R.D. Johnston, Amin Ardestani, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Imaging of Endocytic Trafficking and Extracellular Vesicles Released Under Neratinib Treatment in ERBB2+ Breast Cancer Cells
Sara Santamaria, Maria Cristina Gagliani, Grazia Bellese, et al.
Journal of Histochemistry & Cytochemistry (2021) Vol. 69, Iss. 7, pp. 461-473
Open Access | Times Cited: 10
Sara Santamaria, Maria Cristina Gagliani, Grazia Bellese, et al.
Journal of Histochemistry & Cytochemistry (2021) Vol. 69, Iss. 7, pp. 461-473
Open Access | Times Cited: 10
TAZ promotes PDX1-mediated insulinogenesis
Mi Gyeong Jeong, Hyo Kyeong Kim, Gibbeum Lee, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Closed Access | Times Cited: 7
Mi Gyeong Jeong, Hyo Kyeong Kim, Gibbeum Lee, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Closed Access | Times Cited: 7
Exploration and Clinical Verification of the Blood Co-Expression Genes of Type 2 Diabetes Mellitus and Mild Cognitive Dysfunction in the Elderly
Yu Zhang, Shengfeng Deng, Hongfei Zhong, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 993-993
Open Access | Times Cited: 3
Yu Zhang, Shengfeng Deng, Hongfei Zhong, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 993-993
Open Access | Times Cited: 3
Epinephrine inhibits PI3Kα via the Hippo kinases
Ting-Yu Lin, Shakti Ramsamooj, Tiffany Perrier, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113535-113535
Open Access | Times Cited: 2
Ting-Yu Lin, Shakti Ramsamooj, Tiffany Perrier, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113535-113535
Open Access | Times Cited: 2
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis
Ryan D. Watkins, Ana M. Gamo, Seung Hyuk Choi, et al.
PNAS Nexus (2024) Vol. 3, Iss. 3
Open Access
Ryan D. Watkins, Ana M. Gamo, Seung Hyuk Choi, et al.
PNAS Nexus (2024) Vol. 3, Iss. 3
Open Access
